Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in house dust mite allergic rhinitis patients

被引:0
|
作者
Demoly, P. [1 ,2 ]
Pfaar, O. [3 ]
Gevaert, P. [4 ]
Canonica, G. W. [5 ]
Casale, T. [6 ]
Scurati, S. [7 ]
Dolimier, E. [7 ]
机构
[1] Univ Hosp Montpellier, Montpellier, France
[2] IDESP, Montpellier, France
[3] Philipps Univ Marburg, Univ Hosp Marburg, Marburg, Germany
[4] Univ Ghent, Ghent, Belgium
[5] Humanitas Univ, Milan, Italy
[6] Univ S Florida, Tampa, FL USA
[7] Stallergenes Greer, Antony, France
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
000267
引用
收藏
页码:217 / 218
页数:2
相关论文
共 50 条
  • [21] The effects of house dust mite sublingual immunotherapy in allergic rhinitis children
    Park, Y.
    ALLERGY, 2018, 73 : 622 - 622
  • [22] Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis
    Okubo, Kimihiro
    Masuyama, Keisuke
    Imai, Toru
    Okamiya, Kazuhiro
    Stage, Brian Sonne
    Seitzberg, Dorthe
    Konno, Akiyoshi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (06) : 1840 - +
  • [23] SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms
    Mosbech, Holger
    Canonica, G. Walter
    Backer, Vibeke
    de Blay, Frederic
    Klimek, Ludger
    Broge, Louise
    Ljorring, Christian
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (02) : 134 - U183
  • [24] The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration
    Lin, Zhibin
    Liu, Qihong
    Li, Tianying
    Chen, Dong
    Chen, Dehua
    Xu, Rui
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2016, 6 (01) : 82 - 87
  • [25] Safety of the 300 IR and 500 IR Doses of a House Dust Mite Allergen Extracts Sublingual Tablet in Adults with Allergic Rhinitis
    Nguyen, Helene
    Roux, Michel
    Cognet-Sice, Josiane
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB267 - AB267
  • [26] Safety of a 300IR house dust mite sublingual immunotherapy (SLIT) solution in patients with moderate, persistent asthma
    Devillier, P.
    Fadel, R.
    de Beaumont, O.
    ALLERGY, 2015, 70 : 258 - 258
  • [27] Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites
    Maloney, Jennifer
    Prenner, Bruce M.
    Bernstein, David I.
    Lu, Susan
    Gawchik, Sandra
    Berman, Gary
    Kaur, Amarjot
    Li, Ziliang
    Nolte, Hendrik
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 116 (01) : 59 - 65
  • [28] House dust mite sublingual tablets (Actair®): a guide to their use as allergy immunotherapy for house dust mite-induced allergic rhinitis
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2016, 32 (6) : 219 - 225
  • [29] Immunological Markers In House Dust Mite Allergic Subjects Treated With 300IR House Dust Mite Sublingual Tablets: Results From Two Phase III Trials
    Demoly, Pascal M.
    Bergmann, Karl-Christian
    Okamoto, Yoshitaka
    Abiteboul, Kathy
    Relwani, Kanchan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB204 - AB204
  • [30] Odactra - Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1541): : 37 - 39